(February 7, 2006) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for the year and fourth quarter ended December 31, 2005.

2005 HIGHLIGHTS

• Net sales of $6.283 billion, as compared to $5.624 billion in 2004, an increase of 12 percent.

• Worldwide coronary stent system sales of $2.69 billion, as compared to $2.35 billion in 2004, an increase of 14 percent.

• International launch of TAXUS